Michael Kauffman Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Michael Kauffman.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Michael Kauffman. Michael Kauffman is Director in INFINITY PHARMACEUTICALS, INC. ($INFI) and Director in EPIRUS Biopharmaceuticals, Inc. ($CRXX) and Chief Executive Officer in Karyopharm Therapeutics Inc. ($KPTI) and Director in Verastem, Inc. ($VSTM) and Director in Kezar Life Sciences, Inc. ($KZR).
Latest Insider Trading Transactions of Michael Kauffman
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, CRXX, INFI, KPTI, KZR, VSTM
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 23 2021 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 12.39 | 4,000 | 49,553 | 714,826 | 718.8 K to 714.8 K (-0.56 %) |
Mar 01 2021 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | A | 14.56 | 153,500 | 2,234,960 | 153,500 | |
Mar 01 2021 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | A | 14.56 | 153,500 | 2,234,960 | 153,500 | |
Mar 01 2021 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Grant | A | 0.00 | 57,200 | 0 | 920,152 | 863 K to 920.2 K (+6.63 %) |
Mar 01 2021 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Grant | A | 0.00 | 57,200 | 0 | 718,826 | 661.6 K to 718.8 K (+8.65 %) |
Feb 22 2021 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 14.83 | 9,495 | 140,822 | 776,452 | 785.9 K to 776.5 K (-1.21 %) |
Feb 22 2021 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 14.83 | 9,495 | 140,822 | 575,126 | 584.6 K to 575.1 K (-1.62 %) |
Feb 09 2021 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 0.00 | 14,300 | 0 | 42,900 | |
Feb 09 2021 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 0.00 | 14,300 | 0 | 42,900 | |
Feb 09 2021 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 0.00 | 14,300 | 0 | 770,789 | 756.5 K to 770.8 K (+1.89 %) |
Feb 09 2021 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 0.00 | 14,300 | 0 | 569,422 | 555.1 K to 569.4 K (+2.58 %) |
Oct 14 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 0.03 | 6,076 | 201 | 0 | |
Oct 14 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 0.03 | 1,424 | 47 | 0 | |
Oct 14 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 14.89 | 7,500 | 111,683 | 756,489 | 764 K to 756.5 K (-0.98 %) |
Oct 14 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 0.03 | 6,076 | 201 | 763,989 | 757.9 K to 764 K (+0.80 %) |
Oct 14 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 0.03 | 1,424 | 47 | 757,913 | 756.5 K to 757.9 K (+0.19 %) |
Oct 14 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 0.03 | 6,076 | 201 | 0 | |
Oct 14 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 0.03 | 1,424 | 47 | 0 | |
Oct 14 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 14.89 | 7,500 | 111,683 | 756,489 | 764 K to 756.5 K (-0.98 %) |
Oct 14 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 0.03 | 6,076 | 201 | 763,989 | 757.9 K to 764 K (+0.80 %) |
Oct 14 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 0.03 | 1,424 | 47 | 757,913 | 756.5 K to 757.9 K (+0.19 %) |
Aug 18 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 0.03 | 1,477 | 49 | 6,076 | |
Aug 18 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 15.00 | 1,477 | 22,155 | 756,489 | 758 K to 756.5 K (-0.19 %) |
Aug 18 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 0.03 | 1,477 | 49 | 757,966 | 756.5 K to 758 K (+0.20 %) |
Jul 17 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 0.03 | 7,500 | 248 | 1,424 | |
Jul 17 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 19.43 | 7,500 | 145,723 | 756,489 | 764 K to 756.5 K (-0.98 %) |
Jul 17 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 0.03 | 7,500 | 248 | 763,989 | 756.5 K to 764 K (+0.99 %) |
Jul 13 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 4.75 | 7,500 | 35,640 | 377,803 | |
Jul 13 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 4.75 | 7,500 | 35,640 | 333,561 | |
Jul 13 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 19.53 | 7,500 | 146,487 | 756,489 | 764 K to 756.5 K (-0.98 %) |
Jul 13 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 4.75 | 7,500 | 35,640 | 763,989 | 756.5 K to 764 K (+0.99 %) |
Jul 13 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 19.71 | 300 | 5,912 | 555,122 | 555.4 K to 555.1 K (-0.05 %) |
Jul 13 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 18.98 | 7,200 | 136,627 | 555,422 | 562.6 K to 555.4 K (-1.28 %) |
Jul 13 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 4.75 | 7,500 | 35,640 | 562,622 | 555.1 K to 562.6 K (+1.35 %) |
Jun 26 2020 | KZR | Kezar Life Science ... | Kauffman Michael | Director | Option Exercise | A | 5.60 | 8,896 | 49,818 | 8,896 | |
Jun 24 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 0.03 | 7,500 | 248 | 8,924 | |
Jun 24 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 20.00 | 7,500 | 150,000 | 756,489 | 764 K to 756.5 K (-0.98 %) |
Jun 24 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 0.03 | 7,500 | 248 | 763,989 | 756.5 K to 764 K (+0.99 %) |
Jun 18 2020 | VSTM | Verastem, Inc. | Kauffman Michael | Director | Option Exercise | A | 1.77 | 25,000 | 44,250 | 25,000 | |
Jun 17 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 0.03 | 357 | 12 | 0 | |
Jun 17 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 0.03 | 7,143 | 236 | 16,424 | |
Jun 17 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 16.20 | 357 | 5,783 | 756,489 | 756.8 K to 756.5 K (-0.05 %) |
Jun 17 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 0.03 | 357 | 12 | 756,846 | 756.5 K to 756.8 K (+0.05 %) |
Jun 17 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 16.38 | 7,143 | 116,996 | 756,489 | 763.6 K to 756.5 K (-0.94 %) |
Jun 17 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 0.03 | 7,143 | 236 | 763,632 | 756.5 K to 763.6 K (+0.94 %) |
Jun 11 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 4.75 | 7,500 | 35,640 | 385,303 | |
Jun 11 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 4.75 | 7,500 | 35,640 | 341,061 | |
Jun 11 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 18.50 | 7,500 | 138,746 | 756,489 | 764 K to 756.5 K (-0.98 %) |
Jun 11 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 4.75 | 7,500 | 35,640 | 763,989 | 756.5 K to 764 K (+0.99 %) |
Jun 11 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 18.13 | 7,500 | 135,944 | 555,122 | 562.6 K to 555.1 K (-1.33 %) |
Jun 11 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 4.75 | 7,500 | 35,640 | 562,622 | 555.1 K to 562.6 K (+1.35 %) |
May 19 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 0.03 | 7,500 | 248 | 357 | |
May 19 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 0.03 | 7,500 | 248 | 7,857 | |
May 19 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 20.00 | 7,500 | 150,000 | 756,489 | 764 K to 756.5 K (-0.98 %) |
May 19 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 0.03 | 7,500 | 248 | 763,989 | 756.5 K to 764 K (+0.99 %) |
May 19 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 18.65 | 7,500 | 139,841 | 756,489 | 764 K to 756.5 K (-0.98 %) |
May 19 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 0.03 | 7,500 | 248 | 763,989 | 756.5 K to 764 K (+0.99 %) |
Apr 10 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 4.75 | 10,000 | 47,520 | 400,303 | |
Apr 10 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 4.75 | 10,000 | 47,520 | 356,061 | |
Apr 10 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 18.61 | 10,000 | 186,115 | 756,489 | 766.5 K to 756.5 K (-1.30 %) |
Apr 10 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 4.75 | 10,000 | 47,520 | 766,489 | 756.5 K to 766.5 K (+1.32 %) |
Apr 10 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 20.64 | 10,000 | 206,404 | 555,122 | 565.1 K to 555.1 K (-1.77 %) |
Apr 10 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 4.75 | 10,000 | 47,520 | 565,122 | 555.1 K to 565.1 K (+1.80 %) |
Mar 11 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 4.75 | 10,000 | 47,520 | 410,303 | |
Mar 11 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 4.75 | 10,000 | 47,520 | 366,061 | |
Mar 11 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 22.38 | 3,000 | 67,141 | 756,489 | 759.5 K to 756.5 K (-0.40 %) |
Mar 11 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 22.58 | 7,000 | 158,054 | 759,489 | 766.5 K to 759.5 K (-0.91 %) |
Mar 11 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 4.75 | 10,000 | 47,520 | 766,489 | 756.5 K to 766.5 K (+1.32 %) |
Mar 11 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 22.64 | 2,068 | 46,821 | 555,122 | 557.2 K to 555.1 K (-0.37 %) |
Mar 11 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 22.11 | 7,932 | 175,365 | 557,190 | 565.1 K to 557.2 K (-1.40 %) |
Mar 11 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 4.75 | 10,000 | 47,520 | 565,122 | 555.1 K to 565.1 K (+1.80 %) |
Feb 21 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 16.48 | 8,817 | 145,321 | 756,489 | 765.3 K to 756.5 K (-1.15 %) |
Feb 21 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 16.48 | 8,817 | 145,321 | 555,122 | 563.9 K to 555.1 K (-1.56 %) |
Feb 19 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 0.00 | 21,800 | 0 | 65,400 | |
Feb 19 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 0.00 | 21,800 | 0 | 65,400 | |
Feb 19 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 0.00 | 21,800 | 0 | 765,306 | 743.5 K to 765.3 K (+2.93 %) |
Feb 19 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 0.00 | 21,800 | 0 | 563,939 | 542.1 K to 563.9 K (+4.02 %) |
Feb 07 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | A | 0.00 | 57,200 | 0 | 57,200 | |
Feb 07 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | A | 0.00 | 57,200 | 0 | 57,200 | |
Feb 07 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | A | 18.00 | 153,500 | 2,763,000 | 153,500 | |
Feb 07 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | A | 18.00 | 153,500 | 2,763,000 | 153,500 | |
Jan 10 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 4.75 | 10,000 | 47,520 | 430,303 | |
Jan 10 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 4.75 | 10,000 | 47,520 | 386,061 | |
Jan 10 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Gift | G | 0.00 | 17,313 | 0 | 0 | 17.3 K to 0 (-100.00 %) |
Jan 10 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Gift | G | 0.00 | 17,313 | 0 | 0 | 17.3 K to 0 (-100.00 %) |
Jan 10 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 18.57 | 10,000 | 185,705 | 743,506 | 753.5 K to 743.5 K (-1.33 %) |
Jan 10 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 4.75 | 10,000 | 47,520 | 753,506 | 743.5 K to 753.5 K (+1.34 %) |
Jan 10 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 19.19 | 10,000 | 191,880 | 542,139 | 552.1 K to 542.1 K (-1.81 %) |
Jan 10 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 4.75 | 10,000 | 47,520 | 552,139 | 542.1 K to 552.1 K (+1.84 %) |
Dec 11 2019 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 4.75 | 10,000 | 47,520 | 440,303 | |
Dec 11 2019 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 4.75 | 10,000 | 47,520 | 396,061 | |
Dec 11 2019 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 17.02 | 10,000 | 170,210 | 731,134 | 741.1 K to 731.1 K (-1.35 %) |
Dec 11 2019 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 4.75 | 10,000 | 47,520 | 741,134 | 731.1 K to 741.1 K (+1.37 %) |
Dec 11 2019 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 15.99 | 10,000 | 159,896 | 529,767 | 539.8 K to 529.8 K (-1.85 %) |
Dec 11 2019 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 4.75 | 10,000 | 47,520 | 539,767 | 529.8 K to 539.8 K (+1.89 %) |
Nov 12 2019 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 4.75 | 10,000 | 47,520 | 450,303 | |
Nov 12 2019 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 4.75 | 10,000 | 47,520 | 406,061 | |
Nov 12 2019 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 14.63 | 10,000 | 146,254 | 731,134 | 741.1 K to 731.1 K (-1.35 %) |
Nov 12 2019 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 4.75 | 10,000 | 47,520 | 741,134 | 731.1 K to 741.1 K (+1.37 %) |
Nov 12 2019 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 14.76 | 10,000 | 147,610 | 529,767 | 539.8 K to 529.8 K (-1.85 %) |
Nov 12 2019 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 4.75 | 10,000 | 47,520 | 539,767 | 529.8 K to 539.8 K (+1.89 %) |
Nov 05 2019 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 4.75 | 10,000 | 47,520 | 460,303 | |
Nov 05 2019 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 4.75 | 10,000 | 47,520 | 416,061 | |
Nov 05 2019 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 12.00 | 10,000 | 120,000 | 731,134 | 741.1 K to 731.1 K (-1.35 %) |
Nov 05 2019 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 4.75 | 10,000 | 47,520 | 741,134 | 731.1 K to 741.1 K (+1.37 %) |
Nov 05 2019 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 12.00 | 10,000 | 120,000 | 529,767 | 539.8 K to 529.8 K (-1.85 %) |
Nov 05 2019 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 4.75 | 10,000 | 47,520 | 539,767 | 529.8 K to 539.8 K (+1.89 %) |
Sep 17 2019 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 4.75 | 10,000 | 47,520 | 470,303 | |
Sep 17 2019 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 4.75 | 10,000 | 47,520 | 426,061 | |
Sep 17 2019 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 12.00 | 10,000 | 120,000 | 731,134 | 741.1 K to 731.1 K (-1.35 %) |
Sep 17 2019 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 4.75 | 10,000 | 47,520 | 741,134 | 731.1 K to 741.1 K (+1.37 %) |
Sep 17 2019 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 12.00 | 10,000 | 120,000 | 529,767 | 539.8 K to 529.8 K (-1.85 %) |
Sep 17 2019 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 4.75 | 10,000 | 47,520 | 539,767 | 529.8 K to 539.8 K (+1.89 %) |
Jun 27 2019 | KZR | Kezar Life Science ... | Kauffman Michael | Director | Option Exercise | A | 7.63 | 8,896 | 67,876 | 8,896 | |
Jun 25 2019 | VSTM | Verastem, Inc. | Kauffman Michael | Director | Option Exercise | A | 1.81 | 25,000 | 45,250 | 25,000 | |
Jun 25 2019 | VSTM | Verastem, Inc. | Kauffman Michael | Director | Option Exercise | A | 1.81 | 25,000 | 45,250 | 25,000 | |
Jun 14 2019 | INFI | INFINITY PHARMACEU ... | Kauffman Michael | Director | Option Exercise | A | 1.60 | 30,000 | 48,000 | 30,000 | |
Feb 19 2019 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | A | 0.00 | 87,200 | 0 | 87,200 | |
Feb 19 2019 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | A | 0.00 | 87,200 | 0 | 87,200 | |
Feb 19 2019 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | A | 9.21 | 231,200 | 2,129,352 | 231,200 | |
Feb 19 2019 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | A | 9.21 | 231,200 | 2,129,352 | 231,200 | |
Jan 09 2019 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 0.03 | 12,500 | 413 | 15,357 | |
Jan 09 2019 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 10.23 | 12,500 | 127,824 | 731,134 | 743.6 K to 731.1 K (-1.68 %) |
Jan 09 2019 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 0.03 | 12,500 | 413 | 743,634 | 731.1 K to 743.6 K (+1.71 %) |
Dec 10 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 0.03 | 12,500 | 413 | 27,857 | |
Dec 10 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 10.11 | 12,500 | 126,423 | 713,510 | 726 K to 713.5 K (-1.72 %) |
Dec 10 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 0.03 | 12,500 | 413 | 726,010 | 713.5 K to 726 K (+1.75 %) |
Nov 27 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 4.75 | 9,600 | 45,619 | 436,061 | |
Nov 27 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 11.00 | 9,600 | 105,600 | 512,143 | 521.7 K to 512.1 K (-1.84 %) |
Nov 27 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 4.75 | 9,600 | 45,619 | 521,743 | 512.1 K to 521.7 K (+1.87 %) |
Nov 21 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 4.75 | 400 | 1,901 | 445,661 | |
Nov 21 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 11.14 | 400 | 4,455 | 512,143 | 512.5 K to 512.1 K (-0.08 %) |
Nov 21 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 4.75 | 400 | 1,901 | 512,543 | 512.1 K to 512.5 K (+0.08 %) |
Nov 09 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 0.03 | 12,500 | 413 | 40,357 | |
Nov 09 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 11.65 | 12,500 | 145,593 | 713,510 | 726 K to 713.5 K (-1.72 %) |
Nov 09 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 0.03 | 12,500 | 413 | 726,010 | 713.5 K to 726 K (+1.75 %) |
Oct 22 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 4.75 | 10,000 | 47,520 | 446,061 | |
Oct 22 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 12.63 | 10,000 | 126,304 | 512,143 | 522.1 K to 512.1 K (-1.92 %) |
Oct 22 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 4.75 | 10,000 | 47,520 | 522,143 | 512.1 K to 522.1 K (+1.95 %) |
Oct 09 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 0.03 | 10,736 | 354 | 52,857 | |
Oct 09 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 0.03 | 1,764 | 58 | 0 | |
Oct 09 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 16.13 | 6,000 | 96,767 | 713,510 | 719.5 K to 713.5 K (-0.83 %) |
Oct 09 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 15.39 | 6,500 | 100,066 | 719,510 | 726 K to 719.5 K (-0.90 %) |
Oct 09 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 0.03 | 10,736 | 354 | 726,010 | 715.3 K to 726 K (+1.50 %) |
Oct 09 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 0.03 | 1,764 | 58 | 715,274 | 713.5 K to 715.3 K (+0.25 %) |
Oct 02 2018 | VSTM | Verastem, Inc. | Kauffman Michael | Director | Grant | A | 0.00 | 4,000 | 0 | 8,000 | 4 K to 8 K (+100.00 %) |
Oct 02 2018 | VSTM | Verastem, Inc. | Kauffman Michael | Director | Buy | P | 7.49 | 4,000 | 29,960 | 4,000 | 0 to 4 K |
Sep 18 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 4.75 | 10,000 | 47,520 | 456,061 | |
Sep 18 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 18.26 | 10,000 | 182,615 | 512,143 | 522.1 K to 512.1 K (-1.92 %) |
Sep 18 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 4.75 | 10,000 | 47,520 | 522,143 | 512.1 K to 522.1 K (+1.95 %) |